RII-RIII chloroquine resistantPlasmodium falciparummalaria from East Africa: studies of thein vivoandin vitroresponse to chloroquine
- 1 August 1983
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 77 (4) , 349-354
- https://doi.org/10.1080/00034983.1983.11811723
Abstract
A case is reported of Plasmodium falciparum malaria from East Africa resistant to chloroquine in the in vivo test at the RII level. Serum chloroquine concentrations and the in vitro test indicated RIII resistance. The need for further comparative studies of parasitaemia, serum chloroquine concentration and in vitro chloroquine sensitivity assessment is emphasized.This publication has 16 references indexed in Scilit:
- The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, NigeriaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1981
- Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1981
- Chloroquine sensitivity of Plasmodium falciparum in Ibadan, NigeriaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1980
- In vitro microtechnique for determining the drug susceptibility of cultured parasites of Plasmodium falciparumTransactions of the Royal Society of Tropical Medicine and Hygiene, 1980
- CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM EAST AFRICA:The Lancet, 1979
- Habits of malaria chemoprophylaxis and an analysis of breakdowns in a West African mining townPathogens and Global Health, 1979
- Chloroquine-resistant Plasmodium falciparum malaria in KenyaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1979
- Human Malaria Parasites in Continuous CultureScience, 1976
- STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE 12Journal of Clinical Investigation, 1948